XML 46 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Cash and Marketable Securities (Tables)
12 Months Ended
Dec. 31, 2017
Cash and Cash Equivalents [Abstract]  
Schedule of Investment Components
The components of our investments as of December 31, 2017 are as follows (in millions):
 
Cash & Cash Equivalents
 
Restricted Cash
 
Restricted Marketable Securities
 
Total
Cash
$
54.4

 
$
62.4

 
$

 
$
116.8

Equity securities

 

 
62.0

 
62.0

Total
$
54.4

 
$
62.4


$
62.0

 
$
178.8

The components of our investments as of December 31, 2016 are as follows (in millions):
 
Cash & Cash Equivalents
 
Restricted Cash
 
Restricted Marketable Securities
 
Total
Cash
$
40.5

 
$
60.9

 
$

 
$
101.4

Equity securities

 

 
57.7

 
57.7

Total
$
40.5

 
$
60.9

 
$
57.7

 
$
159.1

Schedule of Restricted Cash
As of December 31, 2017 and 2016, Restricted cash consisted of the following (in millions):
 
As of December 31,
 
2017
 
2016
Affiliate cash
$
18.1

 
$
22.9

Self-insured captive funds
44.3

 
38.0

Total restricted cash
$
62.4

 
$
60.9

Available-for-sale Securities Cost to Fair Value Reconciliation
A summary of our restricted marketable securities as of December 31, 2016 is as follows (in millions):
 
Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Equity securities
$
59.6

 
$
0.2

 
$
(2.1
)
 
$
57.7

A summary of our restricted marketable securities as of December 31, 2017 is as follows (in millions):
 
Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Equity securities
$
64.0

 
$
0.3

 
$
(2.3
)
 
$
62.0

Investment information related to restricted marketable securities
Investing information related to our restricted marketable securities is as follows (in millions):
 
For the Year Ended December 31,
 
2017
 
2016
 
2015
Proceeds from sales of restricted available-for-sale securities
$
4.0

 
$

 
$

Proceeds from sales of nonrestricted available-for-sale securities
$

 
$

 
$
12.8

Gross realized gains
$

 
$

 
$
1.2

Gross realized losses
$

 
$

 
$